FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3129642593> ?p ?o ?g. }

• W3129642593 endingPage "117358" @default.
• W3129642593 startingPage "117358" @default.
• W3129642593 abstract "Reactivation of Human Endogenous Retrovirus K (HERV-K), subtype HML-2, has been associated with pathophysiology of amyotrophic lateral sclerosis (ALS). We aimed to assess the efficacy of antiretroviral therapy in inhibiting HML-2 in patients with ALS and a possible association between the change in HML-2 levels and clinical outcomes. We studied the effect of 24-weeks antiretroviral combination therapy with abacavir, lamivudine, and dolutegravir on HML-2 levels in 29 ALS patients. HML-2 levels decreased progressively over 24 weeks (P = 0.001) and rebounded within a week of stopping medications (P = 0.02). The majority of participants (82%), defined as responders, experienced a decrease in HML-2 at week 24 of treatment compared to the pre-treatment levels. Differences in the evolution of some of the clinical outcomes could be seen between responders and non-responders: FVC decreased 23.69% (SE = 11.34) in non-responders and 12.71% (SE = 8.28) in responders. NPI score decreased 91.95% (SE = 6.32) in non-responders and 53.05% (SE = 10.06) in responders (P = 0.01). Thus, participants with a virological response to treatment showed a trend for slower progression of the illness. These findings further support the possible involvement of HML-2 in the clinical course of the disease." @default.
• W3129642593 created "2021-03-01" @default.
• W3129642593 creator A5000097172 @default.
• W3129642593 creator A5000564787 @default.
• W3129642593 creator A5004926870 @default.
• W3129642593 creator A5006307543 @default.
• W3129642593 creator A5009923001 @default.
• W3129642593 creator A5010426572 @default.
• W3129642593 creator A5010807553 @default.
• W3129642593 creator A5026070292 @default.
• W3129642593 creator A5026748817 @default.
• W3129642593 creator A5038119270 @default.
• W3129642593 creator A5050798393 @default.
• W3129642593 creator A5052372512 @default.
• W3129642593 creator A5060359748 @default.
• W3129642593 creator A5064612611 @default.
• W3129642593 creator A5070233617 @default.
• W3129642593 creator A5075876034 @default.
• W3129642593 creator A5087856014 @default.
• W3129642593 creator A5088499298 @default.
• W3129642593 creator A5090168459 @default.
• W3129642593 date "2021-04-01" @default.
• W3129642593 modified "2023-10-17" @default.
• W3129642593 title "Inhibition of HERV-K (HML-2) in amyotrophic lateral sclerosis patients on antiretroviral therapy" @default.
• W3129642593 cites W2004740864 @default.
• W3129642593 cites W2008949845 @default.
• W3129642593 cites W2017060041 @default.
• W3129642593 cites W2038340694 @default.
• W3129642593 cites W2041535562 @default.
• W3129642593 cites W2064285851 @default.
• W3129642593 cites W2065463268 @default.
• W3129642593 cites W2082318572 @default.
• W3129642593 cites W2090362370 @default.
• W3129642593 cites W2093703170 @default.
• W3129642593 cites W2104901317 @default.
• W3129642593 cites W2116710635 @default.
• W3129642593 cites W2119950848 @default.
• W3129642593 cites W2133945524 @default.
• W3129642593 cites W2138725986 @default.
• W3129642593 cites W2165360324 @default.
• W3129642593 cites W2172065220 @default.
• W3129642593 cites W2192237899 @default.
• W3129642593 cites W2236767140 @default.
• W3129642593 cites W2523572491 @default.
• W3129642593 cites W2602350359 @default.
• W3129642593 cites W2755096673 @default.
• W3129642593 cites W2794780788 @default.
• W3129642593 cites W2886559270 @default.
• W3129642593 cites W2896401613 @default.
• W3129642593 cites W2924839574 @default.
• W3129642593 cites W2955540281 @default.
• W3129642593 cites W2962425929 @default.
• W3129642593 cites W2982641702 @default.
• W3129642593 cites W3017897396 @default.
• W3129642593 cites W3039285173 @default.
• W3129642593 cites W3040840440 @default.
• W3129642593 doi "https://doi.org/10.1016/j.jns.2021.117358" @default.
• W3129642593 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8009857" @default.
• W3129642593 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33653604" @default.
• W3129642593 hasPublicationYear "2021" @default.
• W3129642593 type Work @default.
• W3129642593 sameAs 3129642593 @default.
• W3129642593 citedByCount "23" @default.
• W3129642593 countsByYear W31296425932021 @default.
• W3129642593 countsByYear W31296425932022 @default.
• W3129642593 countsByYear W31296425932023 @default.
• W3129642593 crossrefType "journal-article" @default.
• W3129642593 hasAuthorship W3129642593A5000097172 @default.
• W3129642593 hasAuthorship W3129642593A5000564787 @default.
• W3129642593 hasAuthorship W3129642593A5004926870 @default.
• W3129642593 hasAuthorship W3129642593A5006307543 @default.
• W3129642593 hasAuthorship W3129642593A5009923001 @default.
• W3129642593 hasAuthorship W3129642593A5010426572 @default.
• W3129642593 hasAuthorship W3129642593A5010807553 @default.
• W3129642593 hasAuthorship W3129642593A5026070292 @default.
• W3129642593 hasAuthorship W3129642593A5026748817 @default.
• W3129642593 hasAuthorship W3129642593A5038119270 @default.
• W3129642593 hasAuthorship W3129642593A5050798393 @default.
• W3129642593 hasAuthorship W3129642593A5052372512 @default.
• W3129642593 hasAuthorship W3129642593A5060359748 @default.
• W3129642593 hasAuthorship W3129642593A5064612611 @default.
• W3129642593 hasAuthorship W3129642593A5070233617 @default.
• W3129642593 hasAuthorship W3129642593A5075876034 @default.
• W3129642593 hasAuthorship W3129642593A5087856014 @default.
• W3129642593 hasAuthorship W3129642593A5088499298 @default.
• W3129642593 hasAuthorship W3129642593A5090168459 @default.
• W3129642593 hasBestOaLocation W31296425932 @default.
• W3129642593 hasConcept C126322002 @default.
• W3129642593 hasConcept C142462285 @default.
• W3129642593 hasConcept C143998085 @default.
• W3129642593 hasConcept C203014093 @default.
• W3129642593 hasConcept C2522874641 @default.
• W3129642593 hasConcept C2777869810 @default.
• W3129642593 hasConcept C2779134260 @default.
• W3129642593 hasConcept C2779465607 @default.
• W3129642593 hasConcept C2780593183 @default.
• W3129642593 hasConcept C2780596555 @default.
• W3129642593 hasConcept C2993143319 @default.

• next